These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3675957)

  • 1. Polymethylmethacrylate in chronic hemodialysis. Is it of benefit in patients with uremic neuropathy?
    Di Paolo B; Di Marco T; Cappelli P; Albertazzi A
    ASAIO Trans; 1987; 33(3):293-6. PubMed ID: 3675957
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid improvement of uremic neuropathy on short high-efficiency hemodialysis with special reference to middle molecules.
    Manohar NL; Gorfien PC; Namba T; Louis BM; Lipner HI
    ASAIO Trans; 1987; 33(3):274-9. PubMed ID: 3675953
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of hemodialysis with different membranes on middle molecules and uremic neuropathy.
    Djukanović LJ; Mimić-Oka JI; Potić JB
    Int J Artif Organs; 1989 Jan; 12(1):11-9. PubMed ID: 2538398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Locatelli F
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic hemodialysis. Experience in 59 patients treated with 4614 hemodialyses].
    Höffler D; Opitz A; Schaefer K; Knoop H; Knuth O; Quellhorst E; Henning HV; Scheler F
    Arch Klin Med; 1969; 216(4):324-54. PubMed ID: 5362495
    [No Abstract]   [Full Text] [Related]  

  • 7. MRI for acute neurologic complications in end-stage renal disease patients on hemodialysis.
    Lakadamyali H; Ergün T
    Diagn Interv Radiol; 2011 Jun; 17(2):112-7. PubMed ID: 20683820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan G; Beck GJ; Cheung AK; Daugirdas JT; Greene T; Kusek JW; Allon M; Bailey J; Delmez JA; Depner TA; Dwyer JT; Levey AS; Levin NW; Milford E; Ornt DB; Rocco MV; Schulman G; Schwab SJ; Teehan BP; Toto R;
    N Engl J Med; 2002 Dec; 347(25):2010-9. PubMed ID: 12490682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uremic neuropathy. Clinical and neurophysiological data on patients on chronic hemodialysis treatment].
    Ministeri CM; Mucaria A; Bennici S; Visconti G; Calabrese S; De Gregorio A
    Clin Ter; 1986 Jul; 118(2):89-92. PubMed ID: 3742981
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uremic polyneuropathy. Case studies].
    Fierro B; Fradà G; Li Vecchi M; Raimondo D
    Arch Sci Med (Torino); 1981; 138(4):609-14. PubMed ID: 7340740
    [No Abstract]   [Full Text] [Related]  

  • 12. Granulocyte activation during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
    Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychiatric disorders of patients in the terminal stages of chronic renal failure].
    Martynov IuS; Vantsian OIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):54-9. PubMed ID: 6758445
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
    Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J
    Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and problems in hemodialysis of chronic kidney failure important in clinical practice].
    Würz H; Euchenhofer M; Streicher E
    Z Allgemeinmed; 1971 May; 47(13):692-9. PubMed ID: 5580601
    [No Abstract]   [Full Text] [Related]  

  • 16. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 17. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child.
    McVicar M; Gauthier B; Goodman CT
    Am J Dis Child; 1973 Feb; 125(2):263-5. PubMed ID: 4265477
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Friedman EA
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691049
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of dialysis membranes on lipid parameters].
    de Précigout V
    Nephrologie; 2000; 21(7):359-60. PubMed ID: 11200611
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autonomic insufficiency in dialysis patients].
    Röckel A; Hennemann H; Richwien D; Heidland A
    Verh Dtsch Ges Inn Med; 1975; 81():1001-5. PubMed ID: 1229384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.